XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restatement of Previously Issued Financial Statements - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net (loss) income (numerator):        
Net (loss) income $ (2,027) $ (212) $ (2,448) $ 5,356
Shares (denominator):        
Weighted average number of common shares outstanding used in basic computation (in shares) 20,425,282 20,301,384 20,380,262 20,257,145
Common shares issuable upon vesting of restricted stock (in shares) 0 0 0 71,794
Common shares issuable upon conversion of preferred shares (in shares) 0 0 0 10,125
Shares used in diluted computation (in shares) 20,425,282 20,301,384 20,380,262 20,339,064
Net (loss) income per common share:        
Basic (in dollars per share) $ (0.10) $ (0.01) $ (0.12) $ 0.26
Diluted (in dollars per share) $ (0.10) $ (0.01) $ (0.12) $ 0.26
As Previously Reported        
Net (loss) income (numerator):        
Net (loss) income   $ (19)   $ 5,335
Shares (denominator):        
Weighted average number of common shares outstanding used in basic computation (in shares)   20,301,384   20,257,145
Common shares issuable upon vesting of restricted stock (in shares)   0   71,794
Common shares issuable upon conversion of preferred shares (in shares)   0   10,125
Shares used in diluted computation (in shares)   20,301,384   20,339,064
Net (loss) income per common share:        
Basic (in dollars per share)   $ 0   $ 0.26
Diluted (in dollars per share)   $ 0   $ 0.26